Home

NOI to Sole Source to QuVa Pharma, Inc.

Deadline:06 May 2026, 09:00 GMT-4

Tender information

SAM.gov

BETHESDA, United States

Type
Presolicitation
Procedure
Presolicitation
Ref. number
5816fd15c86b44d69534709710fa32ff
NAICS
325412

The purpose of this acquisition is to purchase 503b compounded Intravenous (IV) Narcotics for patient care. Market research has been conducted with only two responses, from QUVA, the known Compounder and distributor for

Show all tender information

Documents

Show all important dates